UHS Share Price | Universal Health Services, Inc. Stock Analysis & Recommendation

Q: How big is Universal Health Services, Inc.?

Market Cap: As of Jun 18, Universal Health Services, Inc. has a market capitalization of 11,066.13 million, categorizing it as a Mid Cap company.Recent Quarterly Performance: For the latest four quarters, Universal Health Services, Inc. reported net sales of 16,084.07 million and a net profit of 1,218.91 million.Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 6,666.21 million and total assets of 14,853.74 million.

Q: What does Universal Health Services, Inc. do?

Overview:Universal Health Services, Inc. is a holding company that owns and operates acute care hospitals, outpatient facilities, and behavioral healthcare facilities within the hospital industry and is classified as a mid-cap company.Financial Snapshot:Most recent Net Sales: 4,100 Million (Quarterly Results - Mar 2025) Most recent Net Profit: 322 Million (Quarterly Results - Mar 2025) Market-cap: USD 11,066.13 Million (Mid Cap)Key Metrics:P/E: 10.00 Dividend Yield: 50.74% Debt Equity: 0.68 Return on Equity: 18.41% Price to Book: 1.63 Contact Details:Address: 367 S GULPH RD, KING OF PRUSSIA PA: 19406-3121 Tel: 1 610 7683300 Website: https://www.uhsinc.com/

Q: Is Universal Health Services, Inc. technically bullish or bearish?

As of 3 October 2025, the technical trend for Universal Health Services, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and both the weekly and monthly Bollinger Bands indicate bullish conditions. Daily moving averages also support a bullish stance. The KST shows a bullish trend on the weekly but is mildly bearish on the monthly, while Dow Theory reflects a mildly bullish outlook for both weekly and monthly periods. The OBV is bullish across both time frames.In terms of performance, the stock has outperformed the S&P 500 over the past week and month, with returns of 2.87% and 8.79% respectively, compared to the S&P 500's 1.09% and 4.15%. However, over the past year, the stock has underperformed with a return of -4.10% versus the S&P 500's 17.82%. Overall, the current technical stance is bullish, indicating a strong upward momentum.

Q: Is Universal Health Services, Inc. overvalued or undervalued?

As of 17 October 2025, the valuation grade for Universal Health Services, Inc. has moved from attractive to very expensive, indicating a shift towards overvaluation. The company appears to be overvalued based on its P/E ratio of 10, which is significantly lower than the peer average, such as Chemed Corp. with a P/E of 56.91, and its EV to EBITDA ratio of 7.18, which also trails behind peers like Surgery Partners, Inc. at 8.44. Additionally, the PEG ratio stands at a notably low 0.14, suggesting that the stock may not be justified at its current price given its growth prospects.In comparison to its peers, Universal Health Services, Inc. has a lower valuation profile, with its EV to EBIT at 9.61 compared to Chemed Corp.'s 37.72 and Premier, Inc.'s 9.86. Despite a strong recent performance with a 3-year return of 116.60% compared to the S&P 500's 81.19%, the company's 1-year return of -12.64% against the S&P 500's 14.08% highlights potential concerns regarding its sustainability at current valuations. Overall, the stock is assessed as overvalued based on the current metrics and peer comparisons.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

1.12 M

Shareholding (Dec 2025)

FII

18.24%

Held by 312 FIIs

DII

37.02%

Held by 52 DIIs

Promoter

0.53%

How big is Universal Health Services, Inc.?

22-Jun-2025

As of Jun 18, Universal Health Services, Inc. has a market capitalization of $11.07 billion, with recent net sales of $16.08 billion and a net profit of $1.22 billion.

View full answer

What does Universal Health Services, Inc. do?

22-Jun-2025

Universal Health Services, Inc. operates acute care hospitals, outpatient facilities, and behavioral healthcare facilities. As of March 2025, it reported net sales of $4.1 billion and a net profit of $322 million, with a market cap of approximately $11.07 billion.

View full answer

Who are in the management team of Universal Health Services, Inc.?

22-Jun-2025

As of March 2022, the management team of Universal Health Services, Inc. includes Executive Chairman Alan Miller, CEO Marc Miller, Lead Independent Director Eileen McDonnell, and several independent directors: Warren Nimetz, Lawrence Gibbs, Maria Singer, and Elliot Sussman.

View full answer

Is Universal Health Services, Inc. technically bullish or bearish?

07-Oct-2025

As of October 3, 2025, Universal Health Services, Inc. shows a bullish technical trend with strong indicators, having outperformed the S&P 500 recently, although it has underperformed over the past year.

View full answer

Is Universal Health Services, Inc. overvalued or undervalued?

21-Oct-2025

As of October 17, 2025, Universal Health Services, Inc. is considered overvalued due to its low P/E and EV/EBITDA ratios compared to peers, despite strong long-term performance, leading to a valuation grade shift from attractive to very expensive.

View full answer

Compare Universal Health Services, Inc. with Similar Stocks

HCA Healthcare, Inc.Chemed Corp.Tenet Healthcare Corp.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 10.65

The company has declared Positive results for the last 6 consecutive quarters

Market Beating performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Hospital

Market cap

USD 11,816 Million (Small Cap)

P/E

9.00

Industry P/E

Dividend Yield

47.52%

Debt Equity

0.65

Return on Equity

19.01%

Price to Book

1.65

Revenue and Profits:

Net Sales:

4,486 Million

(Quarterly Results - Dec 2025)

Net Profit:

448 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-17.32%

6 Months

-1.22%

1 Year

5.38%

2 Years

4.81%

3 Years

55.78%

4 Years

26.59%

5 Years

33.42%

Universal Health Services, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

8.37%

EBIT Growth (5y)

8.68%

EBIT to Interest (avg)

10.65

Debt to EBITDA (avg)

2.26

Net Debt to Equity (avg)

0.68

Sales to Capital Employed (avg)

1.35

Tax Ratio

22.96%

Dividend Payout Ratio

4.76%

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

12.91%

ROE (avg)

14.74%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.65

EV to EBIT

8.45

EV to EBITDA

6.45

EV to Capital Employed

1.39

EV to Sales

0.97

PEG Ratio

0.31

Dividend Yield

47.52%

ROCE (Latest)

16.49%

ROE (Latest)

19.01%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 123 Schemes (44.19%)

Foreign Institutions

Held by 312 Foreign Institutions (18.24%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 9.05% vs 11.08% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 32.88% vs 53.46% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,486.00",
          "val2": "4,113.70",
          "chgp": "9.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "680.60",
          "val2": "619.30",
          "chgp": "9.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "42.50",
          "val2": "40.10",
          "chgp": "5.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-53.90",
          "val2": "52.60",
          "chgp": "-202.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "447.80",
          "val2": "337.00",
          "chgp": "32.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "115.30%",
          "val2": "114.90%",
          "chgp": "0.04%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 9.71% vs 10.82% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 29.93% vs 61.77% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "17,364.80",
          "val2": "15,827.90",
          "chgp": "9.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,612.80",
          "val2": "2,266.60",
          "chgp": "15.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "157.30",
          "val2": "187.50",
          "chgp": "-16.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-53.90",
          "val2": "62.30",
          "chgp": "-186.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,511.20",
          "val2": "1,163.10",
          "chgp": "29.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "114.80%",
          "val2": "106.30%",
          "chgp": "0.85%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY

Dec'25

Dec'24

Change(%)

Net Sales

4,486.00

4,113.70

9.05%

Operating Profit (PBDIT) excl Other Income

680.60

619.30

9.90%

Interest

42.50

40.10

5.99%

Exceptional Items

-53.90

52.60

-202.47%

Consolidate Net Profit

447.80

337.00

32.88%

Operating Profit Margin (Excl OI)

115.30%

114.90%

0.04%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2025 is 9.05% vs 11.08% in Dec 2024

Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is 32.88% vs 53.46% in Dec 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

17,364.80

15,827.90

9.71%

Operating Profit (PBDIT) excl Other Income

2,612.80

2,266.60

15.27%

Interest

157.30

187.50

-16.11%

Exceptional Items

-53.90

62.30

-186.52%

Consolidate Net Profit

1,511.20

1,163.10

29.93%

Operating Profit Margin (Excl OI)

114.80%

106.30%

0.85%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 9.71% vs 10.82% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 29.93% vs 61.77% in Dec 2024

All Annual Results

Company CV

About Universal Health Services, Inc.

Universal Health Services, Inc.

Hospital

Universal Health Services, Inc. is a holding company. The Company's principal business is owning and operating, through its subsidiaries, acute care hospitals and outpatient facilities, and behavioral healthcare facilities. The Company's segments include Acute Care Hospital Services, Behavioral Health Services and Other. As of August 1, 2018, the Company owned and/or operated more than 326 inpatient facilities, and 32 outpatient and other facilities, located in 37 states, Washington, District of Columbia, the United Kingdom, Puerto Rico and the United States Virgin Islands. The Company's hospitals provide a range of services, such as oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services. As of February 28, 2017, its acute care facilities located in the United States included 26 inpatient acute care hospitals; four free-standing emergency departments, and four outpatient surgery/cancer care centers and one surgical hospital.

Company Coordinates

Company Details

367 S GULPH RD , KING OF PRUSSIA PA : 19406-3121

Tel: 1 610 7683300

https://www.uhsinc.com/

Registrar Details